-
公开(公告)号:US11339367B2
公开(公告)日:2022-05-24
申请号:US15094077
申请日:2016-04-08
Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
Inventor: Christiane Gerke , Francesco Berlanda Scorza , Allan Saul , Luana Maggiore
Abstract: Hyperblebbing Shigella strains are generated by disrupting one or more components of the Tol-Pal system. The blebs from these strains are useful immunogens for vaccination. The individual proteins found in these blebs can also be used as immunogens.